Jin Won Hyun Selected Research

Jin Won Hyun Research Topics

Disease

36	Neoplasms (Cancer) 07/2024 - 03/2002
23	Colonic Neoplasms (Colon Cancer) 09/2022 - 01/2010
13	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2009
12	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 04/2012
8	Leukemia 04/2024 - 07/2003
7	Melanoma (Melanoma, Malignant) 03/2024 - 02/2013
7	Body Weight (Weight, Body) 01/2016 - 02/2008
6	Lung Neoplasms (Lung Cancer) 07/2024 - 08/2005
5	Atopic Dermatitis (Atopic Eczema) 02/2024 - 01/2013
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 07/2013
5	Skin Diseases (Skin Disease) 01/2023 - 01/2016
4	Carcinoma (Carcinomatosis) 07/2022 - 06/2012
4	Breast Neoplasms (Breast Cancer) 05/2020 - 09/2010
4	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2012
3	Hepatocellular Carcinoma (Hepatoma) 09/2020 - 02/2010
3	Starvation 07/2007 - 11/2005
2	Inflammation (Inflammations) 07/2022 - 09/2021
2	Keratitis 09/2021 - 07/2020
2	Conjunctivitis 09/2021 - 07/2020
2	Carcinogenesis 01/2019 - 01/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016 - 03/2015
2	Arthritis (Polyarthritis) 11/2015 - 01/2012
2	Hypertrophy 04/2013 - 12/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2024
1	Hyperglycemia 06/2023
1	Infections 01/2023
1	Alopecia (Baldness) 12/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 09/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 09/2021

Drug/Important Bio-Agent (IBA)

20	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2024 - 10/2009
19	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2007
10	AntioxidantsIBA 06/2023 - 01/2009
8	Messenger RNA (mRNA)IBA 07/2023 - 04/2012
7	Particulate MatterIBA 04/2024 - 07/2020
7	Caspase 3 (Caspase-3)IBA 03/2024 - 07/2013
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2009
7	FlavonoidsIBA 07/2016 - 01/2009
6	Caspase 9IBA 03/2024 - 07/2013
6	PhloroglucinolIBA 10/2018 - 02/2006
6	EnzymesIBA 10/2018 - 01/2011
6	SaponinsIBA 12/2013 - 07/2009
6	ginsenoside M1IBA 12/2013 - 07/2009
5	Transcription Factor 3IBA 04/2024 - 04/2012
5	Fluorouracil (Carac)FDA LinkGeneric 04/2018 - 03/2002
4	shikoninIBA 05/2022 - 04/2018
4	CaspasesIBA 05/2022 - 02/2013
4	LuteolinIBA 01/2019 - 06/2013
4	eckolIBA 08/2014 - 11/2005
4	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 07/2013 - 03/2010
3	Histone MethyltransferasesIBA 04/2024 - 06/2016
3	fisetinIBA 01/2022 - 03/2015
3	esculetinIBA 10/2015 - 12/2008
3	Biomarkers (Surrogate Marker)IBA 09/2015 - 08/2012
3	butinIBA 06/2012 - 03/2010
3	8-Hydroxy-2'-DeoxyguanosineIBA 01/2011 - 01/2006
2	Adenosine Triphosphate (ATP)IBA 03/2024 - 01/2010
2	Histones (Histone)IBA 07/2023 - 06/2016
2	baicaleinIBA 06/2023 - 01/2011
2	PolyaminesIBA 06/2023 - 09/2021
2	SpermidineIBA 06/2023 - 09/2021
2	CytokinesIBA 01/2023 - 10/2018
2	CateninsIBA 12/2022 - 11/2016
2	NaphthoquinonesIBA 05/2022 - 04/2018
2	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 04/2018
2	Cytochromes c (Cytochrome c)IBA 01/2022 - 01/2020
2	Retinaldehyde (Retinal)IBA 09/2021 - 01/2021
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2021 - 01/2018
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2020 - 07/2003
2	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2019 - 05/2016
2	Cadherins (E-Cadherin)IBA 04/2018 - 01/2018
2	Histone Deacetylases (Histone Deacetylase)IBA 07/2017 - 12/2013
2	Transcription Factors (Transcription Factor)IBA 07/2017 - 09/2014
2	Matrix Metalloproteinases (MMPs)IBA 11/2015 - 01/2012
2	coumarinIBA 10/2015 - 12/2008
2	Ethanol (Ethyl Alcohol)IBA 01/2015 - 06/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2014 - 03/2012
2	8-hydroxyguanineIBA 01/2013 - 01/2006
2	CatalaseIBA 01/2011 - 07/2007
2	cholest-5-en-3 beta,7 alpha-diolIBA 08/2005 - 03/2002
1	Histone-Lysine N-MethyltransferaseIBA 04/2024
1	naringeninIBA 03/2024
1	Dinitrochlorobenzene (DNCB)IBA 02/2024
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 07/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 07/2023
1	p38 Mitogen-Activated Protein KinasesIBA 06/2023
1	Melanocyte-Stimulating Hormones (MSH)IBA 06/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	Vehicle Emissions (Emissions, Vehicle)IBA 01/2023
1	limoninIBA 12/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2022
1	platycodin DIBA 07/2022
1	5-bromo-3,4-dihydroxybenzaldehydeIBA 03/2022
1	bis(diazo)benzidine (BDB)IBA 03/2022
1	Air Pollutants (Pollutants, Air)IBA 09/2021
1	Ophthalmic Solutions (Eye Drops)IBA 09/2021

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2022 - 03/2002
5	Therapeutics 07/2017 - 03/2008
1	Immunotherapy 01/2022
1	Radiotherapy 01/2022